Centogene N.V.
CNTGF
$0.1411
$0.0118.46%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -3.41% | -0.98% | 13.75% | 13.90% | 122.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.41% | -0.98% | 13.75% | 13.90% | 122.13% |
| Cost of Revenue | 9.68% | 12.45% | 22.03% | 16.48% | 111.49% |
| Gross Profit | -19.84% | -17.82% | 1.56% | 9.60% | 37.19% |
| SG&A Expenses | 10.88% | 13.68% | 12.14% | 11.34% | -27.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -17.84% | -20.81% | -264.08% | 30.34% | -82.86% |
| Total Operating Expenses | 1.29% | 3.84% | 6.58% | 5.43% | 148.03% |
| Operating Income | -9.71% | -12.47% | 0.68% | 2.93% | 56.36% |
| Income Before Tax | 27.54% | 25.71% | -5.76% | -5.39% | 43.97% |
| Income Tax Expenses | 500.82% | 510.74% | -96.19% | 55.56% | 86.24% |
| Earnings from Continuing Operations | 25.36% | 23.48% | -4.27% | -5.40% | 43.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -79.58% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.74% | 19.77% | -19.63% | -80.22% | 37.49% |
| EBIT | -9.71% | -12.47% | 0.68% | 2.93% | 56.36% |
| EBITDA | -16.48% | -25.51% | -1.52% | -25.36% | 59.69% |
| EPS Basic | 25.50% | 23.62% | -17.21% | -50.14% | 45.92% |
| Normalized Basic EPS | -15.55% | -18.42% | -3.64% | 12.21% | 60.50% |
| EPS Diluted | 24.75% | 22.88% | -17.21% | -50.14% | 45.30% |
| Normalized Diluted EPS | -15.55% | -18.42% | -3.64% | 12.21% | 60.50% |
| Average Basic Shares Outstanding | 5.01% | 5.01% | 2.05% | 20.05% | 21.11% |
| Average Diluted Shares Outstanding | 5.01% | 5.01% | 2.05% | 20.05% | 21.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
